These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9308772)

  • 21. The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey.
    Gürgey A; Mesci L
    Turk J Pediatr; 1997; 39(3):313-5. PubMed ID: 9339109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on recognition and management of patients with acquired or inherited hypercoagulability.
    Alving B
    Compr Ther; 1998; 24(6-7):302-9. PubMed ID: 9669094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent thromboembolism in two unrelated patients with double heterozygosity for factor V R506Q and factor II 20210G/A mutations.
    Veyradier A; Wolf M; Boyer-Neumann C; Parent F; Simonneau G; Meyer D
    Thromb Haemost; 1998 Jul; 80(1):201-2. PubMed ID: 9684812
    [No Abstract]   [Full Text] [Related]  

  • 25. [Breakthrough in thrombosis research--can the use of contraceptive pills be safer than it used to be?].
    Lähteenmäki P
    Duodecim; 1995; 111(22):2097-8. PubMed ID: 9841168
    [No Abstract]   [Full Text] [Related]  

  • 26. Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables.
    Lowe GD; Rumley A; Woodward M; Reid E; Rumley J
    Thromb Haemost; 1999 Jun; 81(6):918-24. PubMed ID: 10404768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee.
    Björkman A; Burtscher IM; Svensson PJ; Hillarp A; Besjakov J; Benoni G
    Arch Orthop Trauma Surg; 2005 Feb; 125(1):51-5. PubMed ID: 15723247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of factor V(Q506) and prothrombin 20210 A mutations in an apparently healthy Icelandic population and patients suffering from venous thrombosis.
    Olafsson I; Hjaltadóttir S; Onundarson PT; Pórarinsdóttir R; Haraldsdóttir V
    Thromb Haemost; 1998 Mar; 79(3):685-6. PubMed ID: 9531063
    [No Abstract]   [Full Text] [Related]  

  • 29. Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation.
    Faisel F; Romppanen EL; Hiltunen M; Helisalmi S; Laasanen J; Punnonen K; Salonen JT; Heinonen S
    Eur J Hum Genet; 2004 Mar; 12(3):187-91. PubMed ID: 14673478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism.
    Ro A; Hara M; Takada A
    Thromb Haemost; 1999 Dec; 82(6):1769. PubMed ID: 10613669
    [No Abstract]   [Full Text] [Related]  

  • 31. World distribution of factor V Leiden.
    Dzimiri N; Meyer B
    Lancet; 1996 Feb; 347(8999):481-2. PubMed ID: 8618525
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
    Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
    Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between longevity and allelic forms of human leukocyte antigens (HLA): population study of aged Italian human subjects.
    Ricci G; Colombo C; Ghiazza B; Illeni MT
    Arch Immunol Ther Exp (Warsz); 1998; 46(1):31-4. PubMed ID: 9510943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assays.
    Galli M; Duca F; Ruggeri L; Finazzi G; Negri B; Moia M
    Thromb Haemost; 1998 Aug; 80(2):246-9. PubMed ID: 9716147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor V Leiden and venous thrombosis in Danish centenarians.
    Kristensen SR; Andersen-Ranberg K; Bathum L; Jeune B
    Thromb Haemost; 1998 Nov; 80(5):860-1. PubMed ID: 9843185
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of factor V Leiden in accelerated forms of coronary artery disease.
    Fang JC; Miletich JP; Ridker PM
    Thromb Haemost; 1997 Sep; 78(3):1161-2. PubMed ID: 9308773
    [No Abstract]   [Full Text] [Related]  

  • 39. Absence of factor V Leiden mutation in Koreans.
    Kim YW; Yoon KY; Park S; Shim YS; Cho HI; Park SS
    Thromb Res; 1997 Apr; 86(2):181-2. PubMed ID: 9175239
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutant factor V (Arg506Gln) in healthy centenarians.
    Mari D; Mannucci PM; Duca F; Bertolini S; Franceschi C
    Lancet; 1996 Apr; 347(9007):1044. PubMed ID: 8606584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.